Federal Character
  • Home
  • News
  • Politics
  • Business & Finance
  • Entertainment
  • Sports
  • Tech
  • Relationship and Life
  • Fashion & Lifestyle
  • Food & Nutrition
  • Health
  • Opinion
No Result
View All Result
  • Home
  • News
  • Politics
  • Business & Finance
  • Entertainment
  • Sports
  • Tech
  • Relationship and Life
  • Fashion & Lifestyle
  • Food & Nutrition
  • Health
  • Opinion
No Result
View All Result
Federal Character
No Result
View All Result
Home Health

Gilead’s Promising Injectable HIV Prevention Medication Offers New Hope in the Fight Against HIV

Christabel EgbeamabyChristabel Egbeama
June 21, 2024
in Health
0
Gilead’s Promising Injectable HIV Prevention Medication Offers New Hope in the Fight Against HIV
Share on FacebookShare on TwitterShare on Whatsapp

Gilead Sciences is making waves in the fight against HIV with their promising injectable HIV prevention medication.

HIV (Human Immunodeficiency Virus) is a long-standing sexually transmitted disease (STD) that affects millions of people around the world. It concerns HIV carriers, their families, and the healthcare industry. However, despite extensive research by scientists and researchers to develop novel treatments and preventative methods for HIV, there is still no definitive cure.

Why is that so? This is due to the biological properties of the HIV virus, which hinder efforts to find a permanent treatment. Basically, once HIV infects a person, it inserts its viral DNA into the host’s genome, thereby integrating into the host’s cellular makeup.

Photo by Geralt

HIV is good at targeting the immune system, which reduces the body’s ability to fight infections and diseases. Even after numerous research, doctors remain determined to find preventive methods for this condition. One key step in this ongoing battle is the invention of pre-exposure prophylaxis (PrEP), a preventive method for people at high risk of developing HIV.

Table of Contents

Toggle
  • The Problem
  • The Solution
  • Is The New Injectable PrEP Promising?
  • Conclusion

The Problem

Pre-exposure prophylaxis (PrEP) is a drug for uninfected people who are at high risk of contracting HIV through sexual contact or needle sharing. Previously, the only approved type of PrEP was daily oral drugs such as Truvada and Descovy.

Let’s be honest: not everyone like oral medication, especially if it’s not an encapsulated pill. As much as people wish to protect themselves from HIV, they sometimes get caught up in life and forget to take their medications. A pre-exposure medicine must be used constantly to prevent the virus from establishing itself in the body of an uninfected person.

The Solution

Gilead Sciences is one of the foremost HIV researchers. Gilead Sciences’ researchers have made a significant contribution by developing a long-acting injectable form of PrEP. Gilead’s new HIV prevention injection, lenacapavir, is currently undergoing further studies.

Photo by Belova59

Lenacapavir belongs to a class of drugs known as capsid inhibitors. It works by targeting a specific portion of the HIV virus known as the capsid, which is the protein shell that contains the virus’s genetic information. The breakdown of the capsid prevents the virus from replicating and spreading throughout the body.

Furthermore, this innovation improves HIV prevention by making it easier for people to stick to their treatment. The long-acting injectable type of PrEP, which is administered once or twice a month, requires fewer doses and reduces the risk of missing one. This allows the drug to act constantly providing stronger protection against HIV.

Is The New Injectable PrEP Promising?

The PURPOSE 1 trial, a large clinical study designed to assess the efficacy of a specific HIV prevention technique, was done on cisgender women. This phase 3 clinical trial found a surprising 100% effectiveness rate.

All of the patients who received this treatment remained HIV-negative throughout the research, showing that it worked properly for them. Researchers are now investigating if this medication is effective for other groups, which could help more people remain HIV-free.

Conclusion

HIV remains a severe global health issue with no cure due to its capacity to integrate into the body’s DNA. However, there has been substantial progress in HIV prevention, particularly with the introduction by Gilead Sciences of a long-acting injectable PrEP known as lenacapavir.

Furthermore, this new medicine targets the structure of the HIV virus and is easy to follow through. The recent PURPOSE 1 trial showed that it was 100% effective in preventing HIV in cisgender women, showing that it has the potential to drastically reduce the disease globally.

Tags: federal characterGileadGilead's Promising Injectable HIV Prevention Medication Offers New Hope in the Fight Against HIVhealthHIVMedicationprevention
Christabel Egbeama

Christabel Egbeama

Christabel Egbeama is a health writer and aspiring consultant engineer who recently completed her bachelor's degree in civil engineering. Her passion for safety in the construction industry led her to delve into public health writing. Having undergone training in health, safety, and environment, Christabel has established a foundation rich in comprehending the broader spectrum of health and its benefits for individuals across various ages and professions. She now produces compelling holistic health articles aimed at guiding individuals towards informed decisions for a healthier tomorrow, encouraging lifestyle modifications.

Related Posts

Health Sector Held Hostage in Dangote–NUPENG Clash
Health

Health Sector Held Hostage in Dangote–NUPENG Clash

September 8, 2025
Senegal Confirms Mpox Case: Patient in Isolation as Health Officials Monitor Spread
Health

Senegal Confirms Mpox Case: Patient in Isolation as Health Officials Monitor Spread

August 25, 2025
Beware: Fake Cowbell “Our Milk” Hits Nigerian Shops
Health

Beware: Fake Cowbell “Our Milk” Hits Nigerian Shops

August 22, 2025
Next Post
Argentina Begins Copa América Title Defense with 2-0 Win Over Canada

Argentina Begins Copa América Title Defense with 2-0 Win Over Canada

UEFA Euro 2024: Thrilling Draws and Narrow Wins Define Group Stage Matches

UEFA Euro 2024: Thrilling Draws and Narrow Wins Define Group Stage Matches

Namibia Strikes Down Colonial-Era Anti-Gay Laws

Namibia Strikes Down Colonial-Era Anti-Gay Laws

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

Gombe State Government Exposes 523 Ghost Workers After Implementing Biometric Verification Register

Gombe State Government Exposes 523 Ghost Workers After Implementing Biometric Verification Register

2 years ago
Covenant University graduate turns down mouth-watering job offers to become village teacher

Covenant University graduate turns down mouth-watering job offers to become village teacher

4 years ago
Hong Kong Becomes Pioneer in AI Education: Junior Secondary Students to Learn ChatGPT in New Curriculum

Hong Kong Becomes Pioneer in AI Education: Junior Secondary Students to Learn ChatGPT in New Curriculum

2 years ago
The court finds INEC in error for stopping the CVR exercise

Elon Musk is introducing verification badges in gold, grey, and blue on Twitter.

3 years ago

Categories

  • Beauty
  • Business & Finance
  • Entertainment
  • Fashion & Lifestyle
  • Food & Nutrition
  • Government
  • Health
  • News
  • Politics
  • Relationship and Life
  • Sports
  • Tech

Topics

2023 Aboki/Bureau De Change (BDC) apc Arsenal buhari Business cbn chelsea china court Davido Dollar Efcc Election Entertainment Euro and Pounds To Naira Exchange Rate For Today exchange rates for the Nigerian Naira (NGN) Fashion federal character federal government Finance food Football Foreign News government health inec Israel lagos Manchester United Naira Naira Black Market exchange rates News Nigeria pdp police Politics president protest Russia Sports tinubu trump ukraine US
No Result
View All Result

Highlights

Who’s Paying for Trump’s $300 Million Ballroom?

Psychologist’s Grave Warning About Trump

“I Am Not Done”: Kamala Harris Hints at 2028 Run, Defining Her Post-Presidency Path

Louvre Evacuates Jewels to Bank After Security Failure

Shina Peters Details Bizarre Plan That Helped Him Rebuild His Reputation

Sunderland​‍​‌‍​‍‌ Stun Chelsea with Late Winner to Climb Second in Premier League

Trending

Manchester United Hit Four Past Brighton to Seal Third Straight Premier League Win
Sports

Manchester United Hit Four Past Brighton to Seal Third Straight Premier League Win

byHashim Kolawole
October 25, 2025
0

Manchester​‍​‌‍​‍‌ United kept the good vibe going with Ruben Amorim by winning 4-2 against Brighton at Old...

Mystery Donor Gives $130M to Pentagon for Troops' Pay, Sparking Backlash

Mystery Donor Gives $130M to Pentagon for Troops’ Pay, Sparking Backlash

October 25, 2025
“We Want to Breathe”: Hundreds March in Tunis Over Worsening Pollution Crisis

“We Want to Breathe”: Hundreds March in Tunis Over Worsening Pollution Crisis

October 25, 2025
Who’s Paying for Trump’s $300 Million Ballroom?

Who’s Paying for Trump’s $300 Million Ballroom?

October 25, 2025
Psychologist’s Grave Warning About Trump

Psychologist’s Grave Warning About Trump

October 25, 2025

We launched Federal Character in February 2021 based on the belief that the world is in need of smarter and more efficient reporting of events shaping our rapidly changing world. We pledged to put our audience first, always.

Recent News

  • Manchester United Hit Four Past Brighton to Seal Third Straight Premier League Win
  • Mystery Donor Gives $130M to Pentagon for Troops’ Pay, Sparking Backlash
  • “We Want to Breathe”: Hundreds March in Tunis Over Worsening Pollution Crisis

Categories

  • Beauty
  • Business & Finance
  • Entertainment
  • Fashion & Lifestyle
  • Food & Nutrition
  • Government
  • Health
  • News
  • Politics
  • Relationship and Life
  • Sports
  • Tech

© 2024 FederalCharacter.com

No Result
View All Result
  • Home
  • News
  • Politics
  • Business & Finance
  • Entertainment
  • Sports
  • Tech
  • Relationship and Life
  • Fashion & Lifestyle
  • Food & Nutrition
  • Health
  • Opinion

© 2024 Federalcharacter.com